A vital part of your comprehensive offering for patients with Barrett's esophagus with dysplasia [1,2].
Patients experienced less post-procedure pain and need for narcotic medication [4].
Highly effective and durable response through 2 years:
1-year results:
95% CED
88% CEIM
[2,3]
2-year results:
95% CED
90%CEIM
Ready to ablate a wide range of patients
Highly effective in both naive and refractory patients with Barrett's esophagus
New catheter designs reach tubular structures, gastroesophageal junction (GEJ), and lesions big and small [2]
C2 CryoBalloon™ 90° Standard Catheter ablating treatment naive tissue
C2 CryoBalloon™ Focal Pear Catheter at GEJ
To discover the full C2 CryoBalloon™ experience click here.
1. Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, et al. Development of quality indicators for endoscopic eradication therapies in Barrett’s esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett’s Esophagus) Consortium. Am J Gastroenterol. 2017;112(7):1032-1048.
2. Canto MI, Shaheen NJ, Almario JA, Voltaggio L, Montgomery E, Lightdale CJ. Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett’s esophagus (with video). Gastrointest Endosc. 2018. [Epub ahead of print]
3. Canto MI. Safety, efficacy, and durability of endoscopic nitrous oxide cryoballoon ablation for eradication of Barrett’s neoplasia. Poster to be presented at: Digestive Disease Week; June 2-5, 2018. Washington, DC.
4. Van Munster SN, Overwater A, Haidry R, Bisschops R, Bergman J, Weusten BL. CryoBalloon ablation of dysplastic Barrett’s esophagus causes shorter duration and less severe post-procedural pain as compared to radiofrequency ablation. Oral presentation to be presented at: Digestive Disease Week; June 2-5, 2018. Washington, DC.
HOYA Corporation to Support Earthquake Relief in Turkey and Syria
We would like to express our deepest sympathies to all those affected by the earthquake that occurred in Turkey and Syria on February 6.
HOYA Corporation has donated a total of 10 million yen to the Japanese Red Cross Society and the Japan Committee for UNICEF to support the disaster relief and recovery efforts in the affected areas.
Donated to:
Japanese Red Cross Society
5 million yen
Japan Committee for UNICEF
5 million yen
Total amount:
10 million yen
In addition, support activities are also conducted at each business division, such as the following: The Vision Care Division, which manufactures and sells eyeglass lenses, are collecting donations from employees around the world with matching contributions to organizations to support relief efforts in each country. The division will also donate 1,000 pairs of eyeglass lenses through the Turkish Optician Associations.
Also, the PENTAX Medical Division, which operates the medical endoscope business, will donate a total customer value of 150,000 euros (approximately 21.2 million yen) worth of gastrointestinal endoscopes and single-use bronchoscopes to the hospitals affected by the earthquake.
We sincerely hope for the swift recovery from a disaster in the affected areas.
PENTAX Medical is committed to continuing to be a true partner in education and innovation. That’s why we’re pleased to present the PENTAX INSIGHT Studio Case Reports.
